Nakamura M, Shibazaki M, Nitta Y, Endo Y
Department of Anatomy, School of Medicine, Tohoku University, Sendai, Japan.
J Hepatol. 1998 Jun;28(6):991-9. doi: 10.1016/s0168-8278(98)80348-6.
BACKGROUND/AIMS: Injection into mice of a small dose of either a lipopolysaccharide or interleukin-1 induces a slowly developing accumulation of 5-hydroxytryptamine, predominantly in the liver. We have established that this 5-hydroxytryptamine accumulation is the result of the translocation of platelets to hepatic sinusoidal spaces and, further, into Disse spaces, and that the platelets make direct contact with hepatocytes. In the present study, we report our recent findings on this phenomenon.
Platelets contain a large amount of 5-hydroxytryptamine, but the 5-hydroxytryptamine content of the liver is normally very small. Therefore, the translocation of platelets to the liver was assessed by measuring 5-hydroxytryptamine as in previous studies, and it was also analysed by electron microscopy.
Anti-platelet agents, such as heparin and inhibitors of prostaglandin synthesis, were ineffective in preventing the lipopolysaccharide-induced accumulation of 5-hydroxytryptamine in the liver. Of the various cytokines tested, only interleukin-1 and tumour necrosis factor induced such an accumulation of 5-hydroxytryptamine. Intravenous injection of liposomes encapsulating dichloromethylene bisphosphonate resulted in an almost complete depletion of macrophages from the liver. The lipopolysaccharide- and cytokine-induced hepatic accumulations of 5-hydroxytryptamine were abolished almost completely in such macrophage-depleted mice. Electron microscopy revealed no accumulation of platelets in the liver after injection of lipopolysaccharide into the macrophage-depleted mice. Surprisingly, in normal mice injected with lipopolysaccharide, several platelets were found inside some hepatocytes, even though there was no visible damage to these hepatocytes. In fact, there were many polysomes around the degranulated platelets within the hepatocytes, suggesting an enhanced protein synthesis.
These results suggest that, in response to lipopolysaccharide, interleukin-1 or tumour necrosis factor, platelets translocate into the liver in a way that is different from aggregation, and that some, at least, enter hepatocytes. During these processes, hepatic macrophages play an essential role.
背景/目的:给小鼠注射小剂量脂多糖或白细胞介素-1会诱导5-羟色胺缓慢积累,主要在肝脏中。我们已经确定这种5-羟色胺积累是血小板转移至肝窦间隙并进一步进入狄氏间隙的结果,并且血小板与肝细胞直接接触。在本研究中,我们报告了关于这一现象的最新发现。
血小板含有大量5-羟色胺,但肝脏中的5-羟色胺含量通常非常少。因此,如先前研究一样,通过测量5-羟色胺来评估血小板向肝脏的转移,并且还通过电子显微镜进行分析。
抗血小板药物,如肝素和前列腺素合成抑制剂,在预防脂多糖诱导的肝脏中5-羟色胺积累方面无效。在测试的各种细胞因子中,只有白细胞介素-1和肿瘤坏死因子诱导了这种5-羟色胺积累。静脉注射包裹二氯亚甲基二膦酸盐的脂质体导致肝脏中巨噬细胞几乎完全耗尽。在这种巨噬细胞耗尽的小鼠中,脂多糖和细胞因子诱导的肝脏5-羟色胺积累几乎完全消除。电子显微镜显示,向巨噬细胞耗尽的小鼠注射脂多糖后,肝脏中没有血小板积累。令人惊讶的是,在注射脂多糖的正常小鼠中,尽管这些肝细胞没有明显损伤,但在一些肝细胞内发现了几个血小板。事实上,肝细胞内脱颗粒血小板周围有许多多聚核糖体,表明蛋白质合成增强。
这些结果表明,响应脂多糖、白细胞介素-1或肿瘤坏死因子,血小板以不同于聚集的方式转移至肝脏,并且至少有一些进入肝细胞。在这些过程中,肝脏巨噬细胞起着至关重要的作用。